Europe Lab-on-a-chip and Microarrays (Biochip) Market Trends

Statistics for the 2023 & 2024 Europe Lab-on-a-chip and Microarrays (Biochip) market trends, created by Mordor Intelligence™ Industry Reports. Europe Lab-on-a-chip and Microarrays (Biochip) trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Europe Lab-on-a-chip and Microarrays (Biochip) Industry

This section covers the major market trends shaping the Europe Biochip Market according to our research experts:

Microarrays are Expected to Exhibit a Significant Growth During the Forecast Period.

Microarrays are expected to show significant growth in the market during the forecast period, owing to the growing burden of morbidity and mortality due to chronic diseases and novel technologies developing in the market. 

According to the European Cardiovascular Disease Statistics, 2017, around 45% of all the death is caused due to cardiovascular diseases and almost 37% of deaths in the European Union are due to cardiovascular diseases. Microarrays are capable of profiling lncRNA and mRNA expression in atherosclerotic plaques. 

Furthermore, in 2019, Quotient Limited received an approval (CE Mark) for Immunohematology (IH) Microarray for use with its MosaiQ diagnostic platform. Therefore, the aforementioned factors are expected to boost the demand for microarrays in the market over the forecast period.

Europe Biochip market Trend.png

Europe Lab-on-a-Chip and Microarrays Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)